THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Share this Article:
Tweet
|
Company
QualiMed
Headquarters
Winsen, Denmark
Management
Eric K. Mangiardi, CEO
Description
The company is focused on three areas of intervention: Interventional Cardiology, Peripheral Vascular, and Non-Vascular applications.. To continually innovate, QualiMed augments its team with talented individuals that like the evolutionary change that the company is bringing to the market from its biodegradable, micro-invasive, and localized drug delivery technologies. QualiMed’s people, coupled with the clinicians and patients, deserve a better standard of care and have that opportunity to deliver this through its innovative platforms. QualiMed differentiates itself by developing a localized delivery tool to increase the localized penetration of the drug or therapy
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info